Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
13 hedge funds and large institutions have $305K invested in Monogram Orthopaedics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.26% more ownership
Funds ownership: 0% → 0.26% (+0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$231K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$65.8K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$25.9K |
| 4 |
Morgan Stanley
New York
|
+$24.3K |
| 5 |
TPCW
TD Private Client Wealth
New York
|
+$18.1K |
Top Sellers
MGRM Hedge Fund Activity: Q2 2023 in Review
13 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q2 2023, worth a combined $305K.
Buyers outnumbered sellers: 13 funds opened new MGRM positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $231K.
- 13 institutional investors held Monogram Orthopaedics (MGRM) as of Q2 2023, up from 0 in Q1 2023.
- Funds reported $305K of Monogram Orthopaedics stock for Q2 2023.
- 13 funds opened new Monogram Orthopaedics positions in Q2 2023 and 0 closed out, a net change of +13 holders.
- The largest Monogram Orthopaedics buyer in Q2 2023 was UBS Group, an estimated $231K added.
Based on aggregated 13F filings for Q2 2023.